These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 17636667)
1. WITHDRAWN: Cytomegalovirus prophylaxis with antiviral agents for solid organ transplantation. Couchoud-Heyer C Cochrane Database Syst Rev; 2007 Jul; 1998(4):CD001320. PubMed ID: 17636667 [TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus prophylaxis with antiviral agents for solid organ transplantation. Couchoud C Cochrane Database Syst Rev; 2000; (2):CD001320. PubMed ID: 10796773 [TBL] [Abstract][Full Text] [Related]
3. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Vernooij RW; Michael M; Ladhani M; Webster AC; Strippoli GF; Craig JC; Hodson EM Cochrane Database Syst Rev; 2024 May; 5(5):CD003774. PubMed ID: 38700045 [TBL] [Abstract][Full Text] [Related]
4. Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients. Owers DS; Webster AC; Strippoli GF; Kable K; Hodson EM Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD005133. PubMed ID: 23450558 [TBL] [Abstract][Full Text] [Related]
5. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Hodson EM; Ladhani M; Webster AC; Strippoli GF; Craig JC Cochrane Database Syst Rev; 2013 Feb; (2):CD003774. PubMed ID: 23450543 [TBL] [Abstract][Full Text] [Related]
6. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Hodson EM; Barclay PG; Craig JC; Jones C; Kable K; Strippoli GF; Vimalachandra D; Webster AC Cochrane Database Syst Rev; 2005 Oct; (4):CD003774. PubMed ID: 16235341 [TBL] [Abstract][Full Text] [Related]
7. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Hodson EM; Craig JC; Strippoli GF; Webster AC Cochrane Database Syst Rev; 2008 Apr; (2):CD003774. PubMed ID: 18425894 [TBL] [Abstract][Full Text] [Related]
8. Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients. Strippoli GF; Hodson EM; Jones CJ; Craig JC Cochrane Database Syst Rev; 2006 Jan; (1):CD005133. PubMed ID: 16437521 [TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus prophylaxis with antiviral agents in solid organ transplantation: a meta-analysis. Couchoud C; Cucherat M; Haugh M; Pouteil-Noble C Transplantation; 1998 Mar; 65(5):641-7. PubMed ID: 9521197 [TBL] [Abstract][Full Text] [Related]
10. Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients. Kalil AC; Levitsky J; Lyden E; Stoner J; Freifeld AG Ann Intern Med; 2005 Dec; 143(12):870-80. PubMed ID: 16365468 [TBL] [Abstract][Full Text] [Related]
11. Preemptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients. Strippoli GF; Hodson EM; Jones C; Craig JC Transplantation; 2006 Jan; 81(2):139-45. PubMed ID: 16436954 [TBL] [Abstract][Full Text] [Related]
12. Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. Hodson EM; Jones CA; Webster AC; Strippoli GF; Barclay PG; Kable K; Vimalachandra D; Craig JC Lancet; 2005 Jun 18-24; 365(9477):2105-15. PubMed ID: 15964447 [TBL] [Abstract][Full Text] [Related]
13. Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients. Hodson EM; Jones CA; Strippoli GF; Webster AC; Craig JC Cochrane Database Syst Rev; 2007 Apr; (2):CD005129. PubMed ID: 17443573 [TBL] [Abstract][Full Text] [Related]
14. New developments in the management of cytomegalovirus infection after solid organ transplantation. Eid AJ; Razonable RR Drugs; 2010 May; 70(8):965-81. PubMed ID: 20481654 [TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus infection after liver transplantation: current concepts and challenges. Razonable RR World J Gastroenterol; 2008 Aug; 14(31):4849-60. PubMed ID: 18756591 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Antiviral Agents in Preventing Allograft Rejection Following CMV Prophylaxis in High-Risk Kidney Transplantation: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Ruenroengbun N; Sapankaew T; Chaiyakittisopon K; Phoompoung P; Ngamprasertchai T Front Cell Infect Microbiol; 2022; 12():865735. PubMed ID: 35433502 [TBL] [Abstract][Full Text] [Related]
17. [Cytomegalovirus infection after solid-organ transplantation, its risk factors, direct and indirect effects and prevention strategies]. Varga M; Remport A; Czebe K; Péter A; Toronyi E; Sárváry E; Fehérvári I; Sulyok B; Járay J Orv Hetil; 2008 Mar; 149(12):551-8. PubMed ID: 18343771 [TBL] [Abstract][Full Text] [Related]
18. Prevention and management of cytomegalovirus infection in solid-organ transplantation. Mwintshi K; Brennan DC Expert Rev Anti Infect Ther; 2007 Apr; 5(2):295-304. PubMed ID: 17402844 [TBL] [Abstract][Full Text] [Related]
19. Preventing post-organ transplantation cytomegalovirus disease with ganciclovir: a meta-analysis comparing prophylactic and preemptive therapies. Small LN; Lau J; Snydman DR Clin Infect Dis; 2006 Oct; 43(7):869-80. PubMed ID: 16941368 [TBL] [Abstract][Full Text] [Related]
20. Prophylaxis of cytomegalovirus infection in liver transplantation: a randomized trial comparing a combination of ganciclovir and acyclovir to acyclovir. NIDDK Liver Transplantation Database. Badley AD; Seaberg EC; Porayko MK; Wiesner RH; Keating MR; Wilhelm MP; Walker RC; Patel R; Marshall WF; DeBernardi M; Zetterman R; Steers JL; Paya CV Transplantation; 1997 Jul; 64(1):66-73. PubMed ID: 9233703 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]